What it sells
Operating layer for life sciences labs
Business model breakdown
Buyer: who owns the budget?
UnverifiedLab directors / operations heads at biotech, CRO, diagnostics labs.
Trigger: what makes them buy now?
Fragmented instrument and spreadsheet data, slow sample intake and manual CoA reporting, audit readiness.
Workflow: what inputs become what output?
Connect instruments and apps, harmonize data, automate analysis, sample intake and CoAs in an ELN/LIMS/QMS LabOS.
Economics: what it saves and how it charges
Claims ~100-150 scientist-hours/month saved, 70% faster sample intake, CoAs in under 2 minutes; 200+ labs.
Distribution: how it reaches customers
Book a Demo / consultation.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-06-04 | Series A | $8-million USD | Y Combinator | news.google.com |
| — | Y Combinator Summer 2021 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.